---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294506062.md"
description: "Castle Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY2026 sales guidance above estimates."
datetime: "2026-07-30T20:54:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294506062.md)
  - [en](https://longbridge.com/en/news/294506062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294506062.md)
generator: "portal-rs"
---

# 

Castle Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY2026 sales guidance above estimates.

### Related Stocks

- [CSTL.US](https://longbridge.com/en/quote/CSTL.US.md)

## Related News & Research

- [Castle Biosciences COO Kristen Oelschlager reports disposal of common shares worth $138,510.72](https://longbridge.com/en/news/297953128.md)
- [238,204 Shares in Castle Biosciences, Inc. $CSTL Acquired by Advisors Capital Management LLC](https://longbridge.com/en/news/296578673.md)
- [Amazon, Meta Are Now Serious Competition to Uncle Sam: Big Tech's AI Debt Boom 'Driving' Treasury Yields Higher, Says Market Commentator](https://longbridge.com/en/news/298182536.md)
- [A Once-in-a-Generation Market Warning Just Flashed. What History Says Happens Next.](https://longbridge.com/en/news/298189834.md)
- [Castle Biosciences Chief Commercial Officer Juvenal Tobin sells 9,050 shares for $317,112.00](https://longbridge.com/en/news/297230683.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**